You are here
Clinical Trials: Heart Disease
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Primary Ovarian Insufficiency
Intervention: Genetic: Cell therapy
Sponsors: Chinese Academy of Sciences; The First Affiliated Hospital of Zhengzhou University; National Natural Science Foundation of China
Recruiting
Intervention: Genetic: Cell therapy
Sponsors: Chinese Academy of Sciences; The First Affiliated Hospital of Zhengzhou University; National Natural Science Foundation of China
Recruiting
Condition: Exercise
Intervention: Behavioral: Types of Exercise
Sponsors: East Carolina University; American Heart Association
Recruiting
Intervention: Behavioral: Types of Exercise
Sponsors: East Carolina University; American Heart Association
Recruiting
Condition: Myocardial Infarction
Interventions: Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.; Procedure: Surgery by sternotomy
Sponsors: Fundació Institut Germans Trias i Pujol; Germans Trias i Pujol Hospital
Not yet recruiting
Interventions: Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.; Procedure: Surgery by sternotomy
Sponsors: Fundació Institut Germans Trias i Pujol; Germans Trias i Pujol Hospital
Not yet recruiting
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Biological: Allogeneic adipose-derived stromal cells (CSCC_ASC); Other: Control group
Sponsors: JKastrup; University Medical Centre Ljubljana
Not yet recruiting
Interventions: Biological: Allogeneic adipose-derived stromal cells (CSCC_ASC); Other: Control group
Sponsors: JKastrup; University Medical Centre Ljubljana
Not yet recruiting
Condition: Hypoplastic Left Heart Syndrome
Interventions: Biological: Autologous (self) mononuclear cells derived from umbilical cord blood; Procedure: Stage II Surgical repair
Sponsors: Timothy J. Nelson; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospital Colorado; Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Interventions: Biological: Autologous (self) mononuclear cells derived from umbilical cord blood; Procedure: Stage II Surgical repair
Sponsors: Timothy J. Nelson; University of Oklahoma; Children's Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospital Colorado; Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Conditions: Heart Failure; Growth Hormone Deficiency
Interventions: Drug: Human growth hormone; Other: Placebo
Sponsor: Federico II University
Not yet recruiting
Interventions: Drug: Human growth hormone; Other: Placebo
Sponsor: Federico II University
Not yet recruiting
Conditions: Diabetes Mellitus, Type 2; Coronary Artery Disease
Interventions: Dietary Supplement: Trans-resveratrol; Dietary Supplement: Placebo
Sponsors: Maine Medical Center; American Heart Association
Recruiting
Interventions: Dietary Supplement: Trans-resveratrol; Dietary Supplement: Placebo
Sponsors: Maine Medical Center; American Heart Association
Recruiting
Condition: Heart Failure With Reduced Ejection Fraction
Intervention: Device: VB-C01
Sponsors: Viscofan; Ministerio de Ciencia e Innovación, Spain
Recruiting
Intervention: Device: VB-C01
Sponsors: Viscofan; Ministerio de Ciencia e Innovación, Spain
Recruiting
Condition: Cardiomyopathy, Familial
Interventions: Other: Electrocardiogram; Other: physical examination; Other: echocardiography; Biological: blood test
Sponsor: University Hospital, Montpellier
Recruiting
Interventions: Other: Electrocardiogram; Other: physical examination; Other: echocardiography; Biological: blood test
Sponsor: University Hospital, Montpellier
Recruiting
Condition: Dilated Cardiomyopathy
Intervention: Biological: Bone marrow derived mononuclear cells and G-CSF
Sponsor: Barts & The London NHS Trust
Not yet recruiting
Intervention: Biological: Bone marrow derived mononuclear cells and G-CSF
Sponsor: Barts & The London NHS Trust
Not yet recruiting
